These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12569391)

  • 21. CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders.
    Thompson MA; Ohnuma K; Abe M; Morimoto C; Dang NH
    Mini Rev Med Chem; 2007 Mar; 7(3):253-73. PubMed ID: 17346218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis.
    Morimoto C; Lord CI; Zhang C; Duke-Cohan JS; Letvin NL; Schlossman SF
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9960-4. PubMed ID: 7937926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physalis angulata induced G2/M phase arrest in human breast cancer cells.
    Hsieh WT; Huang KY; Lin HY; Chung JG
    Food Chem Toxicol; 2006 Jul; 44(7):974-83. PubMed ID: 16427178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of ultraviolet B-induced cell cycle arrest in G2/M phase in immortalized skin keratinocytes with defective p53.
    Athar M; Kim AL; Ahmad N; Mukhtar H; Gautier J; Bickers DR
    Biochem Biophys Res Commun; 2000 Oct; 277(1):107-11. PubMed ID: 11027648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteasome mediated degradation of CDC25C and Cyclin B1 in Demethoxycurcumin treated human glioma U87 MG cells to trigger G2/M cell cycle arrest.
    Lal N; Nemaysh V; Luthra PM
    Toxicol Appl Pharmacol; 2018 Oct; 356():76-89. PubMed ID: 30009775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HY-1 induces G(2)/M cell cycle arrest in human colon cancer cells through the ATR-Chk1-Cdc25C and Weel pathways.
    Zhao Y; Wu Z; Zhang Y; Zhu L
    Cancer Sci; 2013 Aug; 104(8):1062-6. PubMed ID: 23600770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Chk1-Cdc25C regulation is involved in sensitizing A253 cells to a novel topoisomerase I inhibitor BNP1350 by bax gene transfer.
    Yin M; Hapke G; Guo B; Azrak RG; Frank C; Rustum YM
    Oncogene; 2001 Aug; 20(38):5249-57. PubMed ID: 11536038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas.
    Carbone A; Cozzi M; Gloghini A; Pinto A
    Hum Pathol; 1994 Dec; 25(12):1360-5. PubMed ID: 8001932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells.
    Kajiyama H; Shibata K; Ino K; Mizutani S; Nawa A; Kikkawa F
    Cancer Sci; 2010 Feb; 101(2):347-54. PubMed ID: 19917055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
    Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
    Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/Cdk2.
    Gabrielli BG; Clark JM; McCormack AK; Ellem KA
    J Biol Chem; 1997 Nov; 272(45):28607-14. PubMed ID: 9353326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of UCN-01, staurosporine and CGP 41 251 on cell cycle progression and CDC2/cyclin B1 regulation in A431 cells synchronized at M phase by nocodazole.
    Akiyama T; Shimizu M; Okabe M; Tamaoki T; Akinaga S
    Anticancer Drugs; 1999 Jan; 10(1):67-78. PubMed ID: 10194549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of topoisomerase IIalpha and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials.
    Guo L; Liu X; Nishikawa K; Plunkett W
    Mol Cancer Ther; 2007 May; 6(5):1501-8. PubMed ID: 17513599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest.
    Ujiki MB; Ding XZ; Salabat MR; Bentrem DJ; Golkar L; Milam B; Talamonti MS; Bell RH; Iwamura T; Adrian TE
    Mol Cancer; 2006 Dec; 5():76. PubMed ID: 17196098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGF inhibits the activity of the cyclin B1/CDK1 kinase to induce a transient G₂arrest in RCS chondrocytes.
    Tran T; Kolupaeva V; Basilico C
    Cell Cycle; 2010 Nov; 9(21):4379-86. PubMed ID: 21051949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorogenic substrate [Ala-Pro]2-cresyl violet but not Ala-Pro-rhodamine 110 is cleaved specifically by DPPIV activity: a study in living Jurkat cells and CD26/DPPIV-transfected Jurkat cells.
    Boonacker E; Elferink S; Bardai A; Fleischer B; Van Noorden CJ
    J Histochem Cytochem; 2003 Jul; 51(7):959-68. PubMed ID: 12810846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD26: a novel treatment target for T-cell lymphoid malignancies? (Review).
    Sato K; Dang NH
    Int J Oncol; 2003 Mar; 22(3):481-97. PubMed ID: 12579300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topoisomerase II alpha content and topoisomerase II catalytic activity cannot explain drug sensitivities to topoisomerase II inhibitors in lung cancer cell lines.
    Yamazaki K; Isobe H; Hanada T; Betsuyaku T; Hasegawa A; Hizawa N; Ogura S; Kawakami Y
    Cancer Chemother Pharmacol; 1997; 39(3):192-8. PubMed ID: 8996519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells.
    Hirose Y; Berger MS; Pieper RO
    Cancer Res; 2001 Aug; 61(15):5843-9. PubMed ID: 11479224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.